![Gianni Garotta](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Gianni Garotta
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
OncoNOx ApS
![]() OncoNOx ApS Pharmaceuticals: MajorHealth Technology OncoNOx ApS provides drugs for the treatment of autoimmune diseases and cancer. It is a pharmaceutical company that transforms marketed drugs into proprietary molecules with anti-cancer and/or anti-inflammatory properties. The firm's projects include OX1001 and OX27-NO is a potent anti-cancer compounds in vitro and in vivo and are intended for the treatment of cancer, and OX1001 also exhibits anti-viral activity and is in development for treatment of human immunodeficiency virus (HIV) and acquired immune deficiency syndrome patients with or without HIV related cancer. The company was founded by Ferdinando Nicoletti, Gianni Garotta, Yousef Al-Abed, Marco Donia, and Mai-Britt Zocca in 2011 and is headquartered in Copenhagen, Denmark.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Natimab Therapeutics Srl
![]() Natimab Therapeutics Srl BiotechnologyHealth Technology Natimab Therapeutics Srl operates as a biotechnology company. It specializes in the identification and early-stage clinical development of monoclonal antibodies (mAbs) for the treatment of infectious diseases. The company was founded by Gianni Garotta, Maurizio Denaro, Marianne Murphy and Gerritt Hagens in 2009 and is headquartered in Colleretto Giacosa, Italy.
3
| Holding Company | Biotechnology | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Gianni Garotta tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Maxygen, Inc.
![]() Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Stanford University | College/University | Corporate Officer/Principal | |
LEO Pharma A/S
![]() LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Symbion A/S
![]() Symbion A/S General GovernmentGovernment Symbion A/S provides office communities, meeting facilities, conference facilities, business development and capital for start-up companies. The company was founded in 1986 and is headquartered in Copenhagen, Denmark. | General Government | Corporate Officer/Principal | |
University of Copenhagen | College/University | Corporate Officer/Principal Doctorate Degree | |
University of Southern Denmark | College/University | Doctorate Degree | |
University of Catania | College/University | Corporate Officer/Principal Doctorate Degree | |
FORWARD PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
Dansk Biotek
![]() Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Bracco Imaging SpA
![]() Bracco Imaging SpA Medical SpecialtiesHealth Technology Bracco Imaging SpA manufactures and develops diagnostic imaging solutions for public and private hospitals, imaging centers and private practices. The firm's services include radiology, X-ray imaging, magnetic resonance imaging and ultrasound applications. The company was founded in 1985 and is headquartered in Milan, Italy. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Merck Ltd. | Corporate Officer/Principal | ||
Merck Serono SpA
![]() Merck Serono SpA Pharmaceuticals: MajorHealth Technology Merck Serono SpA engages in the manufacture and sale of specialty pharmaceuticals. The company is headquartered in Rome, Italy. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Amgen BV
![]() Amgen BV Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Amgen BV is a Dutch biotech company that specializes in using living cells to create biologic medicines. The company has helped pioneer the biotech industry and are committed to discovering, developing, manufacturing, and delivering innovative human therapeutics to patients suffering from serious illnesses. Amgen's medicines treat serious illnesses and typically address diseases with a limited number of treatment options. The company has a presence in approximately 100 countries and have reached millions of people with their products. Amgen has a robust pipeline focused on the pursuit of transformative medicines with large effects in serious diseases, using human genetic validation whenever possible to strengthen the evidence base for as many of their programs as possible. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Copenhagen Business Center | Corporate Officer/Principal | ||
Copenhagen University Hospital | College/University | Corporate Officer/Principal | |
Renovaro Biosciences Denmark ApS
![]() Renovaro Biosciences Denmark ApS Miscellaneous Commercial ServicesCommercial Services Dandrit Biotech A/S conducts clinical research, trading, and manufacturing for the pharmaceutical industry. It focuses on research and development of medicines. The company was founded on April 1, 2001 and is headquartered in Hørsholm, Denmark. | Miscellaneous Commercial Services | Chief Executive Officer | |
Galecto Biotech ApS
![]() Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chief Executive Officer | |
Entrepreneurial Learning Lab | Corporate Officer/Principal | ||
IO Biotech ApS
![]() IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Chief Executive Officer Chairman | |
Step Pharma SAS
![]() Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Pharmaceuticals: Major | Chairman | |
Valo Therapeutics Oy
![]() Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Valo Therapeutics Oy is an immunotherapy company based in Helsinki, FI. The Finnish company is focused on developing innovative immunotherapy approaches against cancer and infectious disease. Valo Therapeutics's lead platform, PeptiCRAd, was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. The company is also developing PeptiEnv and PeptiVax, among other neoantigen strategies, in collaboration with Professor Cerullo. The company's PeptiChip technology enables the rapid and accurate identification of tumor antigens. Valo Therapeutics is also developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The company was founded in 2016, and Paul Grant Higham has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member | |
GALECTO, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Cobis A/S
![]() Cobis A/S Miscellaneous Commercial ServicesCommercial Services Cobis A/S provides business support services. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
IO BIOTECH, INC. | Biotechnology | Founder |
Statistiche
Distribuzione geografica
Danimarca | 20 |
Stati Uniti | 6 |
Italia | 5 |
Paesi Bassi | 2 |
Francia | 2 |
Settori
Health Technology | 20 |
Consumer Services | 6 |
Commercial Services | 5 |
Government | 2 |
Posizioni
Corporate Officer/Principal | 17 |
Founder | 13 |
Chief Executive Officer | 10 |
Director/Board Member | 8 |
Chairman | 6 |
Contatti più connessi
Insiders | |
---|---|
Hans Schambye | 16 |
Mai-Britt Zocca | 13 |
Ferdinando Nicoletti | 7 |
Maurizio Denaro | 3 |
Marco Donia | 2 |
Yousef Al-Abed | 1 |
Marianne Murphy | 1 |
Gerrit Hagens | 1 |
- Borsa valori
- Insiders
- Gianni Garotta
- Connessioni Società